Registered Kenya · PPB

C-LEX 500

CEFALEXINE

H2010/22634/184 500MG GENERIC/BIOSIMILARS antiinfectives for systemic use

What it does

Cefalexin is an antibiotic used to treat various bacterial infections.

Commonly used for: skin infections, ear infections, throat infections (pharyngitis), urinary tract infections …

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2010/22634/184
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
CEFALEXINE
Dosage form
500MG
Strength
-
Pack size
10X10
Therapeutic class
GENERIC/BIOSIMILARS
ATC class (WHO)
J01DB - First-generation cephalosporins
RxNorm RxCUI
2231
Manufacturer / MAH
Zawadi Healthcare
Applicant / LTR
ZAWADI HEALTHCARE LIMITED
Country of origin
FOREIGN
Manufacturer location
Shop 2, Next To Gen. Shop, Near Deliverance Church, Off Depot Road, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:28:14 · updated 2026-07-26 09:27:25

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Cefalexin is an antibiotic used to treat various bacterial infections.

What it treats

  • skin infections
  • ear infections
  • throat infections (pharyngitis)
  • urinary tract infections
  • bone infections

How it works

Cefalexin works by killing bacteria or stopping their growth, helping the body to fight off infections.

Who it's for

Cefalexin is for people who have bacterial infections, as determined by a healthcare provider.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: cefalexine

BNF-referenced

Cephalexin is a first generation cephalosporin antibiotic, widely used for treating bacterial infections. It is particularly effective against gram-positive bacteria and is often prescribed for skin and soft tissue infections, respiratory tract infections, and urinary tract infections. The drug works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death.

Indications

  • Skin and soft tissue infections
  • Respiratory tract infections
  • Urinary tract infections
  • Bone infections
  • Otitis media

Dosage

Children: For children, the usual dosage is 25-50 mg/kg/day in divided doses, depending on the type and severity of the infection. Refer to the BNF for Children for specific dosing recommendations.

Adults: The usual adult dose is 500 mg every 6 hours, or 750 mg every 12 hours, depending on the severity of the infection. The maximum daily dose should not exceed 4 g.

Mechanism of action

Cephalexin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins located in the bacterial cytoplasmic membrane. This inhibition prevents the cross-linking of peptidoglycan chains, which are essential for maintaining bacterial cell wall strength and rigidity. As a result, bacterial growth and cell division are inhibited, leading to cell lysis, particularly in rapidly dividing bacteria.

Pharmacodynamics

Cephalexin exhibits bactericidal activity, primarily targeting gram-positive bacteria. It functions by disrupting the synthesis of the bacterial cell wall, which is a critical process for bacterial survival and proliferation. The drug is effective in treating superficial infections that often arise from minor wounds or lacerations, making it a commonly prescribed antibiotic in various clinical settings.

Pharmacokinetics

Cephalexin is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1 hour after oral administration. It is widely distributed throughout the body, including in tissues and body fluids. The drug is primarily excreted unchanged in the urine, with a half-life of approximately 0.5 to 1 hour. Renal function may influence the elimination of cephalexin, thus dose adjustments may be necessary in patients with impaired renal function.

Contra-indications

  • Hypersensitivity to cephalexin or other cephalosporins
  • History of severe allergic reactions to penicillins

Adverse effects

  • Nausea
  • Vomiting
  • Diarrhea
  • Rash
  • Allergic reactions
  • Severe skin reactions
  • Elevated liver enzymes
  • Superinfection with resistant organisms

Interactions

  • Probenecid may increase serum levels of cephalexin
  • May reduce the effectiveness of oral contraceptives

Precautions

  • Caution in patients with renal impairment
  • Caution in patients with a history of gastrointestinal disease, especially colitis
  • Monitor for signs of anaphylaxis in patients with a history of penicillin allergy

Pregnancy

Cephalexin is categorized as pregnancy category B; it should be used during pregnancy only if clearly needed.

Breast-feeding

Cephalexin is excreted in breast milk; caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • Capsules
  • Tablets
  • Oral suspension

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: cefalexine

PubChem CID 27447

Molecular formula: C16H17N3O4S

Mechanism of action

Cephalexin is a first generation cephalosporin antibiotic. Cephalosporins contain a beta lactam and dihydrothiazide. Unlike penicillins, cephalosprins are more resistant to the action of beta lactamase. Cephalexin inhibits bacterial cell wall synthesis, leading breakdown and eventualy cell death. CEPHALOTHIN & ITS CONGENERS INHIBIT BACTERIAL CELL-WALL SYNTHESIS IN MANNER SIMILAR TO THAT OF PENICILLIN. /CEPHALOSPORINS/ The penicillins and their metabolites are potent immunogens because of their ability to combine with proteins and act as haptens for acute antibody-mediated reactions. The most frequent (about 95 percent) or "major" determinant of penicillin allergy is the penicilloyl determinant produced by opening the beta-lactam ring of the penicillin. This allows linkage of the penicillin to protein at the amide group. "Minor" determinants (less frequent) are the other metabolites formed, including native penicillin and penicilloic acids. /Penicillins/ Bactericidal; action depends on ability to reach and bind penicillin-binding proteins located in bacterial cytoplasmic membranes; cephalosporins inhibit bacterial septum and cell wall synthesis, probably by acylation of membrane-bound transpeptidase enzymes. This prevents cross-linkage of peptidoglycan chains, which is necessary for bacterial cell wall strength and rigidity. Also, cell division and growth are inhibited, and lysis and elongation of susceptible bacteria frequently occur. Rapidly dividing bacteria are those most susceptible to the action of cephalosporins. /Cephalosporins/ CEPHALOSPORIN C IS VERY RESISTANT TO ACTION OF PENICILLINASE, FOR WHICH IT IS BOTH COMPETITIVE & NONCOMPETITIVE INHIBITOR, DEPENDING ON SUBSTRATE TESTED... /CEPHALOSPORINS/

Pharmacodynamics

Cephalexin (also called Cefalexin) is a first generation cephalosporin antibiotic. It is one of the most widely prescribed antibiotics, often used for the treatment of superficial infections that result as complications of minor wounds or lacerations. It is effective against most gram-positive bacteria through its inihibition of the cross linking reaction between N-acetyl muramicacid and N-acetylglucosamine in the cell wall, leading to cell lysis.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.